Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Nessler

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Ebiomedicine|October 9, 2019
Antigen-specific immunotherapy for MOG antibody-associated diseasesStefan Nessler
Journal of Neurology|August 7, 2010
Advances in multiple sclerosis research in 2009Stefan Nessler, Wolfgang Brück
Current Opinion in Neurology|April 3, 2025
Recent developments in multiple sclerosis neuropathologyChristine Stadelmann, Jonas Franz, Stefan Nessler
Therapeutic Advances in Neurological Disorders|August 28, 2019
B cell depletion can be effective in multiple sclerosis but failed in a patient with advanced childhood cerebral X-linked adrenoleukodystrophyHendrik Rosewich, Stefan Nessler, Wolfgang Brück, et al.
Current Opinion in Neurology|June 5, 2002
Pathogenesis of multiple sclerosis: an update on immunologyBernhard Hemmer, Sabine Cepok, Stefan Nessler, et al.
Journal of Neuropathology and Experimental Neurology|June 27, 2015
Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile MiceSabine Pfeifenbring, Stefan Nessler, Christiane Wegner, et al.
Neuropathology and Applied Neurobiology|February 3, 2015
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis modelDarius Häusler, Stefan Nessler, Niels Kruse, et al.
Nature Clinical Practice. Neurology|August 26, 2006
Immunopathogenesis and immunotherapy of multiple sclerosisBernhard Hemmer, Stefan Nessler, Dun Zhou, et al.
The International Journal of Neuropsychopharmacology|October 17, 2008
The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokinesPatrick Vollmar, Stefan Nessler, Sudhakar Reddy Kalluri, et al.
Journal of Inherited Metabolic Disease|April 15, 2021
Targeted metabolomics revealed changes in phospholipids during the development of neuroinflammation in Abcd1<sup>tm1Kds</sup> mice and X-linked adrenoleukodystrophy patientsMatthias Kettwig, Henry Klemp, Stefan Nessler, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Ebiomedicine|October 9, 2019
Antigen-specific immunotherapy for MOG antibody-associated diseasesStefan Nessler
Journal of Neurology|August 7, 2010
Advances in multiple sclerosis research in 2009Stefan Nessler, Wolfgang Brück
Current Opinion in Neurology|April 3, 2025
Recent developments in multiple sclerosis neuropathologyChristine Stadelmann, Jonas Franz, Stefan Nessler
Therapeutic Advances in Neurological Disorders|August 28, 2019
B cell depletion can be effective in multiple sclerosis but failed in a patient with advanced childhood cerebral X-linked adrenoleukodystrophyHendrik Rosewich, Stefan Nessler, Wolfgang Brück, et al.
Current Opinion in Neurology|June 5, 2002
Pathogenesis of multiple sclerosis: an update on immunologyBernhard Hemmer, Sabine Cepok, Stefan Nessler, et al.
Journal of Neuropathology and Experimental Neurology|June 27, 2015
Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile MiceSabine Pfeifenbring, Stefan Nessler, Christiane Wegner, et al.
Neuropathology and Applied Neurobiology|February 3, 2015
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis modelDarius Häusler, Stefan Nessler, Niels Kruse, et al.
Nature Clinical Practice. Neurology|August 26, 2006
Immunopathogenesis and immunotherapy of multiple sclerosisBernhard Hemmer, Stefan Nessler, Dun Zhou, et al.
The International Journal of Neuropsychopharmacology|October 17, 2008
The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokinesPatrick Vollmar, Stefan Nessler, Sudhakar Reddy Kalluri, et al.
Journal of Inherited Metabolic Disease|April 15, 2021
Targeted metabolomics revealed changes in phospholipids during the development of neuroinflammation in Abcd1<sup>tm1Kds</sup> mice and X-linked adrenoleukodystrophy patientsMatthias Kettwig, Henry Klemp, Stefan Nessler, et al.
Pageof 6